Clinical Trials
🇺🇸 FDA Page 3FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Access global clinical trial data, regulatory updates, and competitive intelligence for strategic pharma R&D and investment decisions.
Showing 25–36 of 380 articles
Lenacapavir posts 100% HIV prevention in PURPOSE 1
J&J reports positive Phase 3 Tremfya data in ulcerative colitis
Cobenfy meets endpoint in Bristol Myers Squibb’s Alzheimer’s psychosis trial
MariTide Phase 2: Amgen reports up to 20% weight loss at one year
Eli Lilly raises 2026 revenue guidance on Mounjaro demand
Merck’s Harpoon acquisition deepens oncology pipeline ahead of Keytruda risk
Pfizer's Danuglipron Hits Phase 2b Obesity Endpoint
Roche reports positive Phase 3 results for trontinemab in Alzheimer's disease
Triple Hormone-Receptor Agonist Retatrutide for Obesity: Phase 3 Results and Market Impact
Exclusive: FDA issues industry-friendly gene therapy guidance: What BD teams need to know
Johnson And Johnson ASCO 2026 Data Adds Depth To JNJ Valuation Story
Pfizer's Berobenatide Obesity Drug: VESPER-3 Data and Competitive Outlook